Currently, very few therapeutic options are available for HCC but also other hepatic cancers (i.e., ICC, hepatoblastoma), and thus a better understanding of TIA1 but also of other AUBPs may provide new biomarkers and/or novel and efficient therapeutic options. The gene discussed is TIA1; the disease is intrahepatic cholangiocarcinoma.